These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6411921)

  • 1. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
    Giannini EH; Person DA; Brewer EJ; Parks DB
    J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis.
    Fantini F; Cottafava F; Martini A; Murelli M; Franchini E; D'Errico R; Panzarasa R
    Int J Clin Pharmacol Res; 1986; 6(1):61-7. PubMed ID: 3082775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug information: auranofin (Ridaura). Oral administration of gold for polyarthritis].
    MMW Munch Med Wochenschr; 1983 Mar; 125(12):88-9. PubMed ID: 6406850
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological evaluation in children with juvenile chronic arthritis treated with auranofin.
    Martini A; De Amici M; Visconti L; Plebani A; Fornari M; Marconi M; Panzarasa R; Astaldi A; Azzaretti G
    Int J Clin Pharmacol Res; 1985; 5(3):149-55. PubMed ID: 3926662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
    Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
    J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Auranofin (Ridaura). A peroral gold salt].
    Manthorpe R
    Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
    [No Abstract]   [Full Text] [Related]  

  • 15. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A; Kunishima DH; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the kinetics of parenteral and oral gold.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of juvenile rheumatoid arthritis: presentation of 3 protocols].
    Mignone F; Sardella M; Bevivino T; Chicco I; Ciravegna P; Maiullari E
    Minerva Pediatr; 1985 Feb; 37(3):135-40. PubMed ID: 3927124
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Giannini EH; Brewer EJ; Person DA
    Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.